Compared to Estimates, Forrester Research (FORR) Q3 Earnings: A Look at Key Metrics

Forrester Research (FORR) reported $94.3 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 8%. EPS of $0.37 for the same period compares to $0.29 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $99.16 million, representing a surprise of -4.91%. The company delivered an EPS surprise of +19.35%, with the consensus EPS estimate being $0.31.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Forrester Research performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Events: $0.17 million versus $1.83 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -92% change.Revenue- Consulting: $21.48 million versus $22.75 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -8.1% change.Revenue- Research: $72.65 million compared to the $75.28 million average estimate based on three analysts. The reported number represents a change of -5.7% year over year.View all Key Company Metrics for Forrester Research here>>>Shares of Forrester Research have returned -16% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Forrester Research, Inc. (FORR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks